1977 …2022

Research activity per year

Network

Paulo J. Oliveira

  • University of Coimbra
  • CNC-Center for Neuroscience and Cell Biology
  • Center for Neurosciences and Cell Biology
  • Center for Neuroscience and Cell Biology
  • Departamento de Zoologia

External person

M. D. Bailie

  • University of Kansas
  • Michigan State University
  • Departments of Physiology and Pediatrics and Human Development
  • Department of Pharmacology and Toxicology
  • Department of Pediatrics and Human Development

External person

Carlos M. Palmeira

  • University of Coimbra
  • University of Minnesota
  • Center for Neurosciences and Cell Biology
  • Departamento de Zoologia
  • Department of Pharmacology
  • Coimbra
  • Department of Pharmacology
  • University of Coimbra, Marine and Environmental Research Centre
  • Institute for Marine Research

External person

John L. Butenhoff

  • 3M
  • SaluTox LLC
  • L.L.C.
  • Medical Department
  • Corporate Toxicology

External person

J. B. Hook

  • Michigan State University

External person

Christopher Lau

  • Reproduction Toxicology Division
  • United States Environmental Protection Agency
  • Toxicity Assessment Division
  • Toxicity Assessment Division

External person

R. A. Roth

  • Michigan State University
  • Departments of Pharmacology and Toxicology
  • Department of Pharmacology and Toxicology

External person

Shu Ching Chang

  • 3M
  • Medical Department
  • Corporate Toxicology

External person

Jessica Berthiaume

  • 262 Medical School
  • University of Minnesota
  • Department of Biochemistry and Molecular Biology
  • UMD School of Medicine

External person

T. R. Henry

  • University of Minnesota
  • University of Wisconsin
  • American Scientific International, Inc.
  • United States Environmental Protection Agency
  • U.S. Environmental Protection Agency
  • Department of Pharmacology
  • School of Pharmacy
  • Risk Assessment Division
  • Department of Pharmacology

External person

Vilma A. Sardão

  • University of Coimbra
  • Center for Neurosciences and Cell Biology
  • Center for Neuroscience and Cell Biology

External person

David J. Ehresman

  • 3M
  • Medical Department

External person

A. Starkov

  • University of Minnesota
  • Cornell University
  • Department of Biomedical Sciences
  • Neurology and Neuroscience Weill Medical College

External person

L. E. Solem

  • University of Minnesota
  • Oregon State University
  • Biochem. and Biophysics Department
  • Toxicology Graduate Program
  • Department of Pharmacology
  • Department of Pharmacology
  • Department of Medical Microbiology and Immunology
  • Department of Medicine
  • Department of Medical Microbiologyllmmunology
  • Department of Pharmacology
  • Department of Medical Microbiology and Immunology

External person

Antonio J M Moreno

  • University of Coimbra
  • University of Minnesota
  • University of Coimbra, Marine and Environmental Research Centre
  • Institute for Marine Research
  • Center for Neurosciences and Cell Biology
  • Department of Life Sciences
  • CNC-Center for Neuroscience and Cell Biology

External person

G. D. Veith

  • International QSAR Foundation
  • United States Environmental Protection Agency
  • Duluth U.S. Environmental Protection Agency
  • University of Minnesota
  • Environmental Research Laboratory-Duluth
  • Environmental Research Laboratory
  • U.S. Environmental Protection Agency
  • Department of Biology

External person

S. Zhou

  • University of Minnesota

External person

Anabela P. Rolo

  • University of Coimbra
  • Center for Neurosciences and Cell Biology
  • Coimbra

External person

Kaleb C. Lund

  • University of Minnesota
  • School of Medicine 262

External person

S. M. Cohen

  • University of Nebraska Medical Center
  • University of Nebraska
  • Flavor and Extract Manufacturers Association
  • Dept. of Pathology
  • Dept. of Pathology and Microbiology
  • Dept. of Pathology and Microbiology
  • FEMA Expert Panel
  • Dept. of Pathology and Microbiology
  • Dept. of Pathology and Microbiology
  • Department of Pathology and Microbiology
  • Department of Pathology and Microbiology
  • Havlik-Wall Professor of Oncology
  • University of Nebraska Omaha
  • Department of Pathology and Microbiology
  • US Federal Emergency Management Agency
  • Nebraska Medicine

External person

George A. Parker

  • Biotechnics, Inc.
  • Biotechnics, LLC
  • Charles River Laboratories
  • Charles River Pathology Associates
  • Inc.
  • Charles River Laboratories

External person

John M. Rogers

  • United States Environmental Protection Agency
  • Research Triangle Park
  • University of North Carolina
  • Research Triangle Institute International
  • Reproduction Toxicology Division

External person

Melvin E. Andersen

  • CIIT Centers for Health Research
  • Wright-Patterson AFB
  • Armstrong Aerospace Medical Research Laboratory
  • CIIT Centers for Health Research
  • Research Triangle Park
  • Air Force Research Laboratory

External person

Lois Heller

  • University of Minnesota
  • Department of Biomedical Sciences
  • Dept. of Med. and Molec. Physiology
  • Dept. of Med. and Molec. Physiology
  • Department of Physics
  • Department of Pharmacology
  • Department of Physiology and Pharmacology
  • Department of Physiology
  • Departments of Pharmacology and Medical and Molecular Physiology
  • Dept. of Med. and Molec. Physiology
  • Department of Physiology
  • Department of Pharmacology
  • Department of Physiology and Pharmacology

External person

Ian Kimber

  • University of Manchester
  • Manchester Interdisciplinary Biocentre
  • Faculty of Life Sciences

External person

Herman N. Autrup

  • Aarhus University
  • Institute of Public Health

External person

Marcello Lotti

  • University of Padova
  • Section of Respiratory Diseases

External person

D. W. Kuehl

  • United States Environmental Protection Agency
  • Office of Research and Development
  • US EPA Mid-Continent Ecology Division
  • Environmental Research Laboratory
  • National Center for Computational Toxicology
  • Natl. Hlth./Environ. Effects Res. L.

External person

Maria S. Santos

  • University of Coimbra
  • Department of Life Sciences
  • Center for Neurosciences and Cell Biology

External person

E. P. Petkova

  • StrataTox, LLC

External person

Timothy M. O'Brien

  • University of Minnesota

External person

James E. Klaunig

  • Indiana University
  • Department of Environmental Health

External person

J. I. Goodman

  • Michigan State University
  • Flavor and Extract Manufacturers Association
  • Department of Pharmacology and Toxicology
  • FEMA Expert Panel
  • Department of Pharmacology and Toxicology
  • Dept. of Pharmacology and Toxicology
  • Department of Pharmacology and Toxicology
  • Pharmacology & Toxicology Department
  • FEMA Expert Panel
  • US Federal Emergency Management Agency

External person

J. Serrano

  • United States Environmental Protection Agency
  • US EPA Mid-Continent Ecology Division

External person

Helmut A. Greim

  • Technical University of Munich
  • Inst. of Toxicol./Environ. Hygiene
  • Technical University of Munich

External person

Catarina R. Oliveira

  • University of Coimbra
  • Department of Biochemistry
  • Center for Neurosciences and Cellular Biology

External person

Gio B. Gori

  • Regulatory Toxicology and Pharmacology
  • Emeritus
  • Regulatory Toxicology and Pharmacology
  • The Health Policy Center

External person

David W. Gaylor

  • Gaylor and Associates, LLC
  • David W. Gaylor Associates
  • United States Food and Drug Administration

External person

Richard L. Leino

  • University of Minnesota
  • Departments of Anatomy and Cell Biology
  • Depts. Biochem. Molec. Biol. A.
  • Department of Biomedical Anatomy
  • Department of Anatomy
  • Department of Anatomy and Cell Biology
  • Department of Anatomy

External person

M. K. Froberg

  • University of Minnesota
  • Department of Pathology
  • Department of Veterinary Pathobiology
  • Medical School
  • School of Medicine
  • University of Minnesota Twin Cities

External person

Wolfgang Dekant

  • University of Würzburg
  • Member RIFM Expert Panel
  • Universitaet Wuerzburg

External person

Rory B. Conolly

  • CIIT Centers for Health Research
  • CIIT Centers for Health Research
  • Research Triangle Park
  • United States Environmental Protection Agency

External person

Raymond M. David

  • Eastman Kodak

External person

Jon R. Kemp

  • University of Minnesota
  • Department of Pharmacology

External person

M. W. Walters

  • University of Minnesota

External person

Michael Aschner

  • Yeshiva University
  • Department of Molecular Pharmacology
  • Professor
  • Albert Einstein College of Medicine

External person

Elizabeth Hausner

  • United States Food and Drug Administration

External person

James S. Bus

  • Dow Chemical

External person

Andrew R. Leach

  • GlaxoSmithKline

External person

R. C. Grasty

  • University of North Carolina
  • United States Environmental Protection Agency
  • Reproduction Toxicology Division

External person

D. J. Call

  • University of Dubuque
  • University of Wisconsin
  • Lake Superior Research Institute
  • Department of Natural and Applied Science
  • Center for Lake Superior Environmental Studies
  • University of Wisconsin-Superior

External person

James T. MacGregor

  • United States Food and Drug Administration
  • ILSI HESI

External person

J. B A Custodio

  • Portuguese JNICT
  • University of Coimbra
  • University of Minnesota

External person

Norbert E. Kaminski

  • Michigan State University
  • Pharmacology & Toxicology
  • Professor
  • Department of Pharmacology and Toxicology

External person

Martin van den Berg

  • Utrecht University
  • Institute for Risk Assessment Sciences (IRAS)
  • Institute for Risk Assessment Sciences, Utrecht University
  • Toxicology Department

External person

V. M C Madeira

  • University of Coimbra

External person

Edmond Ekué Creppy

  • Universite de Bordeaux
  • Department of Toxicology and Applied Hygiene
  • Lab. of Toxicol. and Applied Hygiene
  • Laboratory of Toxicology
  • Head of Toxicology Department

External person

R. H. Alper

  • Michigan State University
  • Department of Pharmacology and Toxicology

External person

Janice E. Chambers

  • Mississippi State University
  • ILSI Risk Science Institute

External person

Lawrence C. Trost

  • University of Minnesota
  • Department of Pharmacology

External person

Hans W. Marquardt

  • University of Hamburg
  • University Medical Center Hamburg-Eppendorf
  • University of Minnesota
  • University of Hamburg Medical School. Hamburg

External person

L. T. Brooke

  • International QSAR Foundation
  • University of Wisconsin
  • Lake Superior Research Institute
  • Center for Lake Superior Environmental Studies
  • University of Wisconsin-Superior

External person

Julie R. Thibodeaux

  • United States Environmental Protection Agency

External person

Nancy G. Doerrer

  • DC 20005, USA
  • Health and Environmental Sciences Institute

External person

William Slikker

  • U.S. FDA Natl. Ctr. Toxicological R.
  • US FDA Natl. Ctr. Toxicological Res.
  • United States Food and Drug Administration
  • Office of the Director

External person

Susana P. Pereira

  • University of Coimbra
  • Department of Life Sciences
  • University of Porto
  • CNC-Center for Neuroscience and Cell Biology
  • Research Centre in Physical Activity Health and Leisure (CIAFEL)
  • Center for Neuroscience and Cell Biology
  • Center for Neurosciences and Cell Biology

External person

John W. Froehlich

  • Pace Analytical Services Inc.

External person

Kaberi Das

  • United States Environmental Protection Agency
  • Toxicity Assessment Division
  • Toxicity Assessment Division

External person

Steven D. Cohen

  • Massachusetts College of Pharmacy and Health Sciences

External person

Irene Manou

  • EPAA Industry Secretariat

External person

Olavi Pelkonen

  • University of Oulu
  • Professor and Chair Emeritus

External person

Mary L. Eastvold

  • Mayo Clinic
  • Department of Laboratory Medicine and Pathology

External person

Hans W.J. Marquardt

  • University of Minnesota
  • University of Hamburg
  • University Medical Center Hamburg-Eppendorf
  • Experimental and Clinical Toxicology
  • Institute of Experimental and Clinical Pharmacology and Toxicology

External person

Gonçalo C. Pereira

  • University of Coimbra
  • University of Bristol
  • School of Biochemistry
  • Department of Life Sciences
  • Center for Neurosciences and Cell Biology
  • Center for Neuroscience and Cell Biology
  • CNC-Center for Neuroscience and Cell Biology

External person

David C. Dorman

  • CIIT Centers for Health Research
  • CIIT Centers for Health Research
  • Research Triangle Park

External person

Matthew S. Bogdanffy

  • DuPont
  • Newark
  • Wilmington

External person

Beth E. Mileson

  • ILSI Risk Science Institute

External person

Sir Colin L Berry

  • Queen Mary University of London

External person

Jeremiah D. Zitzow

  • 3M
  • Medical Department

External person

Curtis D. Klaassen

  • University of Washington
  • Department of Pharmacology
  • University of Kansas
  • Department of Environmental and Occupational Health Sciences
  • Department of Pharmacology
  • University of Kansas

External person

António J. Moreno

  • University of Coimbra
  • Department of Life Sciences
  • CNC-Center for Neuroscience and Cell Biology

External person

Teresa Cunha-Oliveira

  • University of Coimbra

External person

Malcolm J. York

  • GlaxoSmithKline
  • Bristol-Myers Squibb
  • University of Minnesota
  • Safety Assessment Pathology
  • Clinical Pathology Laboratory

External person

Eugene H. Herman

  • United States Food and Drug Administration
  • University of Minnesota
  • Office of Genetic Drugs

External person

Yvonne Will

  • SCIENTIA LLC

External person

R. Woodrow Setzer

  • United States Environmental Protection Agency
  • Research Triangle Park
  • Research Triangle Institute International

External person

D. Mackay

  • Trent University
  • Advanced Technology and Research Inc.
  • University of Toronto
  • Centre for Environmental Modelling and Chemistry
  • Institute of Biomaterials and Biomedical Engineering
  • University of Toronto

External person

George Daston

  • Miami Valley Innovation Center
  • Procter and Gamble
  • Miami Valley Innovation Center

External person

R. J. Singh

  • Mayo Clinic
  • Mayo College of Medicine
  • Division of Clinical Biochemistry and Immunology
  • Department of Laboratory Medicine and Pathology
  • Department of Laboratory of Medicine and Pathology
  • Department of Laboratory Medicine and Pathology
  • Medicine and Pathology
  • Division of Clinical Biochemistry
  • Mayo Clinic College of Medicine and Science

External person

Alan R. Boobis

  • Imperial College London
  • Professor of Biochemical Pharmacology
  • Division of Infectious Diseases

External person

Corrado L. Galli

  • University of Milan
  • Section of Toxicology and Risk Assessment
  • Department of Pharmacological and Biomolecular Sciences

External person

Larry P. Sheets

  • ILSI Risk Science Institute
  • Bayer Corporation - USA

External person

I. G. Sipes

  • University of Arizona
  • RIFM Expert Panel
  • Health Sciences Center
  • Department of Pharmacology and Toxicology
  • Department of Pharmacology
  • Health Sciences Center

External person

J. A. Arnot

  • Trent University
  • Arnot Research and Consulting
  • University of Toronto
  • Centre for Environmental Modelling and Chemistry
  • Department of Physical and Environmental Sciences
  • University of Toronto
  • Arnot Research and Consulting

External person

Ernest Hodgson

  • North Carolina State University
  • ILSI Risk Science Institute

External person

James Swenberg

  • University of North Carolina
  • University of Minnesota
  • Department of Environmental Sciences and Engineering
  • Dept. of Environ. Sci. and Eng.
  • Department of Pathology
  • Department of Pathology and Laboratory Medicine
  • Lab. Molec. Carcinogenesis M.
  • Department of Environmental Sciences and Engineering
  • Department of Environmental Sciences and Engineering

External person

Marion Ehrich

  • VA-MD Reg. Coll. of Vet. Medicine
  • ILSI Risk Science Institute
  • Virginia Polytechnic Institute and State University
  • Department of Biomedical Sciences and Pathobiology
  • Virginia-Maryland College of Veterinary Medicine

External person

Dale Hattis

  • Clark University

External person

Donald R. Saunders

  • Technology Services Group
  • ILSI Risk Science Institute
  • Technology Services Group

External person

Jennifer Seed

  • United States Environmental Protection Agency
  • Independent Consultant
  • Risk Assessment Division

External person

Maurice Whelan

  • European Commission Joint Research Centre Institute
  • Joint Research Centre

External person

Karen Hamernik

  • OPP
  • ILSI Risk Science Institute
  • OPP
  • U.S. Environmental Protection Agency

External person

Hiroshi Yamazaki

  • Osaka Pref. Inst. of Public Health
  • Vanderbilt University
  • Showa Pharmaceutical University
  • Department of Biochemistry
  • Department of Biochemistry
  • Dean of Graduate School & Professor
  • The Japanese Society for the Study of Xenobiotics
  • Osaka Institute of Public Health

External person

Gordon D. Holt

  • University of Minnesota
  • Oxford GlycoSciences
  • Intel

External person

Lester G. Sultatos

  • UMD New Jersey Medical School
  • ILSI Risk Science Institute
  • Rutgers University-Newark

External person

Igor Mikaelian

  • Preclinical Development Pathology
  • Hoffman-La Roche

External person

A. Siraki

  • National Institutes of Health

External person

M. T D Cronin

  • Liverpool John Moores University

External person

John Turton

  • University College London
  • Prostate Cancer Research Centre

External person

Karen L. Pennington

  • University of Nebraska Medical Center
  • Department of Pathology and Microbiology

External person

Bob Dunn

  • Amgen
  • University of Louisville
  • Ctr. for Oral Hlth./Systemic Disease

External person

David E. Mohrman

  • University of Minnesota
  • Department of Physics
  • Department of Physiology

External person

Martin Lamb

  • Hoffman-La Roche

External person

Filipa S. Carvalho

  • University of Coimbra
  • Center for Neuroscience and Cell Biology
  • Department of Life Sciences
  • CNC-Center for Neuroscience and Cell Biology

External person

Wolf Dettbarn

  • Vanderbilt University

External person

Ana F. Branco

  • University of Coimbra
  • Center for Neurosciences and Cell Biology
  • Center for Neuroscience and Cell Biology
  • Department of Life Sciences
  • CNC-Center for Neuroscience and Cell Biology

External person

Max Schmeling

  • University of Minnesota

External person

Carey N. Pope

  • University of Louisiana at Monroe

External person

Carmen R. Wood

  • United States Environmental Protection Agency
  • Toxicity Assessment Division
  • Toxicity Assessment Division

External person

Ray Stoll

  • Battelle

External person

Jeffrey A. Johnson

  • University of Minnesota
  • University of Wisconsin
  • Centers for Disease Control and Prevention
  • Division of HIV/AIDS Prevention
  • School of Pharmacy
  • School of Pharmacy
  • Department of Pharmacology

External person

Francisco B. Pereira

  • Polytechnic Institute of Coimbra
  • University of Coimbra
  • Centre for Informatics and Systems
  • University of Coimbra, Centre for Informatics and System

External person

Philip Hewitt

  • Merck KGaA

External person

Rosemary Nicklaus

  • AstraZeneca
  • Preclinical Development Pathology
  • AstraZeneca
  • Hoffman-La Roche

External person

Philippe Joudrier

  • INRA Institut National de La Recherche Agronomique

External person

Douglas A. Dawson

  • Ashland University

External person

Denise Bounous

  • Bristol-Myers Squibb

External person

Lu Xiufen Lu

  • University of Alberta
  • Department of Environmental Health Sciences

External person

Jeffrey A. Johnson

  • University of Wisconsin
  • School of Pharmacy

External person

L. C. Tavares

  • University of Coimbra
  • Department of Life Sciences

External person

Nuno Lourenço

  • University of Coimbra
  • Centre for Informatics and Systems
  • University of Coimbra, Centre for Informatics and System

External person

Mathieu Vinken

  • Vrije Universiteit Brussel

External person

Filipa S. Carvalho

  • University of Coimbra
  • Department of Life Sciences
  • Center for Neuroscience and Cell Biology
  • CNC-Center for Neuroscience and Cell Biology

External person

L. M. Ross

  • Michigan State University
  • Departments of Pharmacology and Toxicology

External person

Bradford D. Bagley

  • 3M
  • Medical Department

External person

William Reagan

  • Saofi-Aventis
  • Drug Safety Research and Development
  • Pfizer
  • Saofi-Aventis

External person

Virgilio J J Cadete

  • University of Coimbra

External person

Uri Herzberg

  • University of Minnesota
  • Department of Veterinary Pathobiology
  • Department of Pharmacology
  • Department of Veterinary Pathobiology

External person

Jacob O. Krogstad

  • University of Minnesota

External person

David G. Farrar

  • IneosChlor
  • INEOS Group

External person

Hiroshi Yamazaki

  • The Japanese Society for the Study of Xenobiotics
  • Showa Pharmaceutical University

External person

Mitul Gandhi

  • GlaxoSmithKline
  • Safety Assessment Pathology

External person

Alexander G. Karczmar

  • Loyola University Chicago

External person

Barbara D. Abbott

  • United States Environmental Protection Agency
  • Toxicity Assessment Division
  • Toxicity Assessment Division

External person

David Muirhead

  • University of Nebraska Medical Center
  • Department of Pathology and Microbiology

External person

J. A. Johnson

  • University of Minnesota

External person

J. T. Eells

  • Medical College of Wisconsin
  • Department of Pharmacology and Toxicology
  • Department of Pharmacology and Toxicology

External person

Kenneth E. McMartin

  • Louisiana State University in Shreveport
  • LSU Health Sciences Center - Shreveport
  • NutraSweet Kelco Company
  • Dept. of Pharmacology/Therapeutics
  • Department of Pharmacology and Therapeutics
  • Louisiana State University

External person

Angelo Moretto

  • Department of
  • University of Milan

External person

Lulu Stader

  • Elsevier
  • Dept. Life Sciences

External person

Steve L. Taylor

  • University of Nebraska
  • University of Nebraska Omaha

External person

Hartmut Jaeschke

  • University of Kansas

External person

Inês Baldeiras

  • University of Coimbra

External person

Mauro Salvi

  • University of Padova
  • Università Di Padova

External person

José A. Lumini

  • Health and Leisure
  • Faculty of Health Sciences
  • LABIOMEP - Porto Biomechanics Laboratory
  • Fernando Pessoa University
  • University of Porto

External person

Eric Schultze

  • Johnson and Johnson

External person

Colin L. Berry

  • Queen Mary University of London

External person

Syril Pettit

  • Pfizer
  • Labcorp Drug Development
  • Pfizer

External person

Paulo J. Oliveira

  • CNC-Center for Neuroscience and Cell Biology
  • University of Coimbra

External person

D. W. Roberts

  • Liverpool John Moores University

External person

D. L. Santos

  • Universidade de Trás-os-Montes e Alto Douro

External person

X. Chris Le

  • University of Alberta
  • Department of Environmental Health Sciences
  • Department of Public Health Sciences

External person

Grace Kissling

  • National Institutes of Health
  • Biostatistics Branch
  • Biostatistics and Computational Biology Branch

External person

Juline A. Smith

  • University of Minnesota
  • Department of Physics
  • Dept. of Med. and Molec. Physiology
  • Department of Physiology

External person

Cheryl Zehowski

  • University of Minnesota
  • Department of Biomedical Sciences

External person

Dai Davies

  • AstraZeneca
  • Safety Assessment

External person

Gavin Folkert

  • University of Minnesota

External person

Kapil Saxena

  • University of Minnesota
  • Department of Pharmacology

External person

Hilmi Orhan

  • Ege University

External person

Thomas Williams

  • DC 20005, USA
  • Health and Environmental Sciences Institute

External person

I. Y. Rosenblum

  • Schering-Plough Biopharma
  • University of Minnesota
  • Merck
  • Gen. Toxicol., Drug Safety/Metab.

External person

Mike Stonebrook

  • Johnson and Johnson

External person

Stephanie Padilla

  • NHEERL
  • U.S. Environmental Protection Agency

External person

C. R. Blystone

  • National Institutes of Health
  • Division of the National Toxicology Program
  • National Institutes of Health

External person

Caroline D. Veloso

  • University of Coimbra

External person

Ryan M. Krisko

  • 3M
  • Medical Department

External person

J. Doull

  • University of Kansas
  • Flavor and Extract Manufacturers Association
  • Medical School
  • Dept. of Pharmacology and Toxicology
  • FEMA Expert Panel
  • Medical School
  • Department of Pharmacology and Toxicology
  • Department of Pharmacology

External person

Corrado L. Galli

  • Department of Pharmacological and Biomolecular Sciences
  • University of Milan

External person

Rui A. Carvalho

  • University of Coimbra

External person

Doug Thudium

  • Merck
  • Merck

External person

Ana Burgeiro

  • University of Coimbra

External person

Frank D. Sistare

  • United States Food and Drug Administration
  • Office of Genetic Drugs

External person

Alan Eveland

  • 3M
  • Medical Department

External person

Luciana L. Ferreira

  • University of Coimbra

External person

João L. de Camargo

  • Universidade Estadual Paulista Julio de Mesquita Filho

External person

Sue C. Chang

  • 3M
  • Medical Department
  • Corporate Toxicology

External person

Rui F. Simões

  • University of Coimbra

External person

M. W. Fariss

  • University of Colorado Denver
  • Pharmaceutical Sciences and Cancer Center
  • University of Colorado Anschutz Medical Campus

External person

Ian Roman

  • GlaxoSmithKline
  • Safety Assessment Pathology

External person

Jeffrey L. Osborn

  • Michigan State University
  • Departments of Physiology and Pediatrics and Human Development
  • Department of Pediatrics and Human Development

External person

André Ferreira

  • University of Coimbra

External person

Takamasa Ohnishi

  • University of Nebraska Medical Center
  • University of Nebraska
  • Department of Pathology and Microbiology
  • Department of Oncology
  • University of Nebraska Omaha

External person

Gary D. Lopaschuk

  • University of Alberta
  • Department of Pediatrics
  • Cardiovascular Research Centre
  • Cardiovasc. Disease Research Group
  • Cardiovascular Research Group
  • University of Alberta

External person

Rui P B Sousa

  • University of Coimbra

External person

Robert M. Hollingworth

  • Michigan State University

External person

Dean P. Jones

  • Emory University
  • Division of Pulmonary
  • Department of Biochemistry
  • Department of Biochemistry
  • Department of Medicine
  • School of Medicine

External person

Satoko Kakiuchi-Kiyota

  • University of Nebraska Medical Center
  • Department of Pathology and Microbiology

External person

Peter Clements

  • GlaxoSmithKline
  • Safety Assessment Pathology

External person

C. B. Frederick

  • Rohm and Haas Company
  • Dow Chemical
  • Toxicology Department

External person

Alan L. Metz

  • University of Minnesota
  • Pfizer
  • Drug Safety Eval., Global Res./Dev.
  • Department of Veterinary Pathobiology
  • Department of Large Animal Clinical Sciences
  • Parke-Davis Pharmaceutical Research
  • Depts. Vet. PathoBiology Clin. P.
  • Department of Veterinary Pathobiology
  • Dept. of Veterinary Pathobiology

External person

John E. Dargan

  • University of Minnesota
  • Department of Pharmacology

External person

A. T. Eldefrawi

  • University of Maryland-Baltimore
  • University of Maryland
  • School of Medicine
  • Department of Pharmacology
  • School of Medicine
  • the School of Medicine
  • Department of Pharmacology

External person

Rudy J. Richardson

  • University of Michigan
  • University of Michigan Health Systems

External person

William L. Chen

  • Dow Agro Sciences
  • DowElanco
  • Dow Chemical

External person

Stefan Hockertz

  • University of Hamburg
  • Abteilg. Allgem. Toxikologie

External person

Sally Brady

  • Northwick Park Hospital
  • Imperial College London
  • Department of Clinical Biochemistry

External person

Antonio Ascensão

  • Health and Leisure
  • University of Porto

External person

Paul H. Lieder

  • 3M
  • Medical Department

External person

G. Cortopassi

  • University of California at Davis
  • Department of Molecular Biosciences
  • Dept. of Molecular Biosciences
  • VM: Molecular Biosciences

External person

Susana F. Sampaio

  • University of Coimbra
  • Department of Life Sciences

External person

Daniel Dietrich

  • University of Konstanz

External person

Prägati S. Coder

  • Charles River Laboratories
  • Charles River Laboratories

External person

J. Christopher Corton

  • United States Environmental Protection Agency
  • Integrated System Toxicology Division

External person

T. W. Schultz

  • University of Tennessee, Knoxville
  • University of Tennessee System
  • Member RIFM Expert Panel
  • Department of Comparative Medicine
  • RIFM Expert Panel
  • Department of Comparative Medicine

External person

Ph D., Department of Pharmacology, School of Medicine

  • University of Minnesota
  • Department of Pharmacology

External person

Dana Walker

  • University of Minnesota
  • Bristol-Myers Squibb

External person

W. C. Copeland

  • National Institutes of Health

External person

Cláudio F. Costa

  • University of Coimbra

External person

Shugo Suzuki

  • University of Nebraska Medical Center
  • Department of Pathology and Microbiology

External person

Ana C. Moreira

  • University of Coimbra
  • Center for Neuroscience and Cell Biology
  • Doctoral Programme in Experimental Biology and Biomedicine
  • Department of Life Sciences

External person

Claudia V. Pereira

  • Neurological Research Building
  • University of Miami
  • CNC-Center for Neuroscience and Cell Biology
  • University of Coimbra

External person

Robert E. Carlson

  • University of Minnesota
  • ECOCHEM Research, Inc.

External person

C. Van Pelt

  • ILSI Risk Science Institute

External person

J. P. Rieth

  • ILSI Risk Science Institute

External person

Brian Berridge

  • GlaxoSmithKline
  • Texas A&M University
  • Eli Lilly and Company
  • Greenfield Lilly Research Laboratories
  • Safety Assessment Pathology
  • Department of Veterinary Pathobiology
  • Lilly Research Laboratories

External person

Antonio Toninello

  • University of Padova
  • Università Di Padova

External person

Leonard F. Bjeldanes

  • University of California

External person

Jefry E. Shields

  • SCIENTIA LLC

External person

Michael P. Holsapple

  • International Life Sciences Institute
  • Michigan State University
  • Department of Food Science and Human Nutrition
  • International Life Sciences Institute
  • Michigan State University

External person

J. L.M. Hermens

  • Utrecht University
  • Institute of Risk Assessment Science
  • Research Institute of Toxicology

External person

Mimi J. Lin

  • United States Environmental Protection Agency
  • Toxicity Assessment Division
  • Toxicity Assessment Division

External person

Hans W. Marquardt

  • University of Hamburg Medical School. Hamburg

External person

Lora L. Arnold

  • University of Nebraska Medical Center
  • Department of Pathology and Microbiology

External person

Donald G. Stump

  • WIL Research Laboratories, LLC

External person

Mariusz R. Wieckowski

  • Nencki Institute of Experimental Biology of the Polish Academy of Sciences

External person

José Magalhães

  • Health and Leisure
  • University of Porto

External person

A. P. Autor

  • University of Iowa

External person

Alejo Erice

  • AIDS Clinical Trials Unit
  • Fairview Health Service
  • Hennepin County Medical Center
  • Regions Hospital
  • University of Rochester
  • IRCCS Fondazione Policlinico San Matteo - Pavia
  • Corning Incorporated
  • CHU Saint-Pierre
  • Hospital ASEPEYO
  • Oregon Health and Science University
  • Burroughs Wellcome Co
  • Medical and Research Services
  • Division of Virology
  • Health Sciences Center
  • HIV Programs
  • Servizio di Virologia
  • Aids Clinical Trials Unit
  • HIV/AIDS Program
  • Infectious Disease Unit
  • University of Minnesota
  • Department of Otolaringology/Head and Neck Surgery
  • Department of Therapeutic Radiology
  • Burroughs Wellcome Fund
  • Department of Medicine
  • Departments of laboratory Medicine and Pathology
  • Department of Medicine
  • Department of Medicine
  • Departments of Laboratory Medicine and Pathology
  • Departments of Laboratory Medicine and Pathology
  • Diagnostic Virology Laboratory
  • Medical Service
  • Medicine
  • Departments of Laboratory Medicine and Pathology

External person

Clare Stamp

  • GlaxoSmithKline
  • Safety Assessment Pathology

External person

R. L. Melnick

  • Ron Melnick Consulting, LLC
  • National Institutes of Health
  • Division of the National Toxicology Program

External person

Jeffrey M. Peters

  • Pennsylvania State University

External person

S. Oparil

  • Michigan State University
  • University of Alabama at Birmingham
  • American Heart Association
  • University of Minnesota
  • Steering Committee
  • ALLHAT Regions
  • Department of Medicine
  • Div. Clin. Immunol. and Rheumatology
  • Division of Epidemiology
  • Vascular Biology and Hypertension Program
  • Vascular Biology and Hypertension Program
  • Office of Scientific Affairs
  • Division of Cardiovascular Disease

External person

Donna D. Zhang

  • University of Arizona
  • Department of Pharmacology and Toxicology
  • Department of Pathology
  • University of Alabama at Birmingham

External person

K. B. Wallace

  • University of Minnesota
  • Toxicology Graduate Program
  • Department of Pharmacology

External person

P. J. O'Brien

  • University of Toronto
  • Faculty of Pharmacy
  • University of British Columbia
  • University of Toronto

External person

Elizabeth Murphy

  • National Institutes of Health
  • University of Minnesota
  • Laboratory of Molecular Carcinogenesis
  • Laboratory of Signal Transduction
  • National Marrow Donor Program
  • Be the Match Patient and Health Professional Services
  • Cardiovascular Branch
  • Bldg 10

External person

Alvaro Puga

  • University of Cincinnati
  • National Institute of Environmental Health Science Center for Environmental Genetics
  • Center for Genome Information
  • Department of Environmental Health

External person

R. Johnson

  • United States Environmental Protection Agency
  • University of Minnesota
  • National Center for Computational Toxicology
  • Integrated Biosciences Graduate Program
  • U.S. Environmental Protection Agency
  • US EPA Mid-Continent Ecology Division
  • National Health and Environmental Effects Research Laboratory

External person

La Rae L. Peterson

  • University of Minnesota

External person

K. M. McCormack

  • Michigan State University
  • Departments of Pharmacology and Toxicology

External person

Cláudia M. Deus

  • University of Coimbra

External person

Silvia Magalhães-Novais

  • University of Coimbra
  • Department of Life Sciences

External person

Paul McGill

  • GlaxoSmithKline
  • Safety Assessment Pathology

External person

Michael Madden

  • University of Minnesota
  • Whiteside Institute for Clinical Research
  • Department of Biomedical Sciences
  • Department of Pathology
  • Paleobiology Laboratory

External person

Peter Taggert

  • Merck
  • Merck

External person

J. B. Hook1

  • Michigan State University
  • Departments of Pharmacology and Toxicology

External person

M. I. Rana

  • University of Minnesota

External person

Calvert Louden

  • AstraZeneca
  • AstraZeneca

External person

I. A. Barbosa

  • University of Coimbra
  • King's College London
  • Department of Life Sciences
  • Division of Genetics and Molecular Medicine
  • CNC-Center for Neuroscience and Cell Biology
  • Guy's Hospital

External person